Literature DB >> 30600353

Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers.

Andrea Gallioli1,2, Romain Boissier3,4, Angelo Territo3, Alberto Breda3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30600353     DOI： 10.1007/s00345-018-2611-1

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  9 in total

1.  Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.

Authors:  Sara Monteiro-Reis; Luís Leça; Mafalda Almeida; Luís Antunes; Paula Monteiro; Paula C Dias; António Morais; Jorge Oliveira; Rui Henrique; Carmen Jerónimo
Journal:  Eur J Cancer       Date:  2013-10-04       Impact factor: 9.162

2.  Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.

Authors:  Run-Qi Guo; Geng-Yan Xiong; Kai-Wei Yang; Lei Zhang; Shi-Ming He; Yan-Qing Gong; Qun He; Xue-Ying Li; Zi-Cheng Wang; Zhen-Qing Bao; Xue-Song Li; Kai Zhang; Li-Qun Zhou
Journal:  Urol Oncol       Date:  2018-04-26       Impact factor: 3.498

3.  Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.

Authors:  Jamie Messer; Shahrokh F Shariat; James C Brien; Michael P Herman; Casey K Ng; Douglas S Scherr; Benjamin Scoll; Robert G Uzzo; Mark Wille; Scott E Eggener; Gary Steinberg; John D Terrell; Steven M Lucas; Yair Lotan; Stephen A Boorjian; Jay D Raman
Journal:  BJU Int       Date:  2011-02-14       Impact factor: 5.588

4.  Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.

Authors:  J Alfred Witjes; Juan Morote; Erik B Cornel; Georgios Gakis; F Johannes P van Valenberg; Fernando Lozano; Itay A Sternberg; Ellen Willemsen; Miriam L Hegemann; Yossi Paitan; Ilan Leibovitch
Journal:  Eur Urol Oncol       Date:  2018-07-17

Review 5.  Diagnostic biomarkers in non-muscle invasive bladder cancer.

Authors:  Izak Faiena; Charles J Rosser; Karim Chamie; Hideki Furuya
Journal:  World J Urol       Date:  2018-11-22       Impact factor: 4.226

6.  Considerations on implementing diagnostic markers into clinical decision making in bladder cancer.

Authors:  Yair Lotan; Shahrokh F Shariat; Bernd J Schmitz-Dräger; Marta Sanchez-Carbayo; Feliksas Jankevicius; Marco Racioppi; Sarah J P Minner; Brigitte Stöhr; Pier Francesco Bassi; H Barton Grossman
Journal:  Urol Oncol       Date:  2010 Jul-Aug       Impact factor: 3.498

Review 7.  Can urinary biomarkers replace cystoscopy?

Authors:  Moritz Maas; Jens Bedke; Arnulf Stenzl; Tilman Todenhöfer
Journal:  World J Urol       Date:  2018-10-03       Impact factor: 4.226

Review 8.  Challenges of cancer biomarker profiling.

Authors:  Karim Bensalah; Francesco Montorsi; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2007-10-01       Impact factor: 20.096

Review 9.  An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer.

Authors:  Francesco Soria; Michael J Droller; Yair Lotan; Paolo Gontero; David D'Andrea; Kilian M Gust; Morgan Rouprêt; Marek Babjuk; Joan Palou; Shahrokh F Shariat
Journal:  World J Urol       Date:  2018-06-21       Impact factor: 4.226
  9 in total
  1 in total

Review 1.  DNA Methylation Cancer Biomarkers: Translation to the Clinic.

Authors:  Warwick J Locke; Dominic Guanzon; Chenkai Ma; Yi Jin Liew; Konsta R Duesing; Kim Y C Fung; Jason P Ross
Journal:  Front Genet       Date:  2019-11-14       Impact factor: 4.599
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.